Funder: Pfizer Inc.

Due Dates: March 31, 2026: Full proposal submission deadline

Funding Amounts: $150,000–$250,000 per project (up to $1.5M total funding); project duration ~18 months

Summary: Funds pathology-led quality improvement projects to optimize molecular testing and care coordination for metastatic colorectal cancer (mCRC).

Key Information: Requires ASCP member as pathologist PI/co-PI and participation in ASCP’s PDI analytics platform (fee applies).